rdf:type |
|
lifeskim:mentions |
umls-concept:C0008902,
umls-concept:C0017262,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205314,
umls-concept:C0220901,
umls-concept:C0376515,
umls-concept:C0679622,
umls-concept:C1134719,
umls-concept:C1441616,
umls-concept:C1527349,
umls-concept:C2347946,
umls-concept:C2911684
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-6-25
|
pubmed:abstractText |
Bcl2 is an important prognostic parameter in human breast cancer. However, the evaluation of Bcl2 expression by immunohistochemistry is carried out using arbitrary scoring criteria. In the present study, we evaluated the clinical relevance of a novel, semiquantitative classification of the Bcl2 immunostaining based on both the distribution and the intensity of the staining reaction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1004-14
|
pubmed:meshHeading |
pubmed-meshheading:17372162-Breast Neoplasms,
pubmed-meshheading:17372162-Carcinoma, Ductal, Breast,
pubmed-meshheading:17372162-Cohort Studies,
pubmed-meshheading:17372162-Female,
pubmed-meshheading:17372162-Humans,
pubmed-meshheading:17372162-Immunohistochemistry,
pubmed-meshheading:17372162-Middle Aged,
pubmed-meshheading:17372162-Prognosis,
pubmed-meshheading:17372162-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:17372162-RNA, Messenger,
pubmed-meshheading:17372162-RNA, Neoplasm,
pubmed-meshheading:17372162-Receptors, Estrogen,
pubmed-meshheading:17372162-Receptors, Progesterone,
pubmed-meshheading:17372162-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2007
|
pubmed:articleTitle |
Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast.
|
pubmed:affiliation |
Department of Experimental Pathology, Unit of Clinical Pathology, University of Bologna, Italy. davide.trere@unibo.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|